YIELD10 Bioscience, Inc.
YTENDelisted Jul 19, 2024- Industry
- Agricultural Production-Crops
- SEC CIK
- 0001121702
YIELD10 Bioscience, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Aug 20, 2024; 20 institutions reported holding it in 13F filings for Q1 2024, worth $612.1K in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in YIELD10 Bioscience, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q1 2021
- Shares held
- 1.07M
- −156.2K (−12.7%) vs. Q1 2021
- Total value
- $9.12M
- −$6.25M (−40.7%) vs. Q1 2021
- New holders
- 3
- 7 more added
- Sold out
- 4
- 7 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YTEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 20 | $612.1K |
| Q4 2023 | 18 | $144.6K |
| Q3 2023 | 18 | $206.5K |
| Q2 2023 | 14 | $1.51M |
| Q1 2023 | 13 | $1.34M |
| Q4 2022 | 16 | $797.0K |
| Q3 2022 | 14 | $1.19M |
| Q2 2022 | 15 | $1.01M |
| Q1 2022 | 17 | $4.35M |
| Q4 2021 | 16 | $4.28M |
| Q3 2021 | 16 | $5.66M |
| Q2 2021 | 21 | $9.12M |
| Q1 2021 | 23 | $15.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding YIELD10 Bioscience, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 27 | $0 | 0.00% | +1+3.8% | Added |
| Salem Investment Counselors Inc | 1 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Resources Management Corp | 250 | $2.00K | 0.00% | 00.0% | Unchanged |
| Hanson & Doremus Investment Management | 242 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,515 | $13.0K | 0.00% | +679+81.2% | Added |
| JPMorgan Chase & Co | 1,566 | $13.0K | 0.00% | +1,566 | New |
| Hussman Strategic Advisors, Inc. | 6,200 | $53.0K | 0.01% | +6,200 | New |
| Two Sigma Investments, LP | 19,733 | $168.0K | 0.00% | −11,678−37.2% | Reduced |
| Renaissance Technologies LLC | 23,000 | $196.0K | 0.00% | −13,600−37.2% | Reduced |
| Two Sigma Advisers, LP | 23,200 | $198.0K | 0.00% | +5,700+32.6% | Added |
| Dimensional Fund Advisors LP | 23,681 | $202.0K | 0.00% | +23,681 | New |
| Marshall Wace North America L.P. | 27,111 | $231.0K | 0.00% | −4,372−13.9% | Reduced |
| Geode Capital Management, LLC | 33,190 | $283.0K | 0.00% | +2,530+8.3% | Added |
| BlackRock Inc. | 41,250 | $351.0K | 0.00% | +3,551+9.4% | Added |
| Millennium Management LLC | 57,917 | $494.0K | 0.00% | −10,563−15.4% | Reduced |
| Worth Venture Partners, LLC | 79,672 | $680.0K | 0.25% | −9,628−10.8% | Reduced |
| Morgan Stanley | 83,510 | $712.0K | 0.00% | −118,562−58.7% | Reduced |
| Vanguard Group Inc | 115,427 | $985.0K | 0.00% | +37,871+48.8% | Added |
| Cannell Peter B & Co Inc | 189,453 | $1.62M | 0.05% | +30,003+18.8% | Added |
| AIGH Capital Management LLC | 342,000 | $2.92M | 0.79% | −38,000−10.0% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −37,774−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −18,952−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,249−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −560−100.0% | Sold out |
| Fairpointe Capital LLC | – | – | – | – | Not filed |